Basel Medical Group Ltd (NASDAQ:BMGL – Get Free Report) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totaling 159,585 shares, an increase of 1,917.0% from the August 31st total of 7,912 shares. Currently, 10.1% of the shares of the stock are sold short. Based on an average daily trading volume, of 3,135,507 shares, the short-interest ratio is currently 0.1 days.
Basel Medical Group Stock Down 7.1%
BMGL opened at $3.80 on Friday. The company has a current ratio of 1.88, a quick ratio of 1.83 and a debt-to-equity ratio of 0.93. Basel Medical Group has a one year low of $3.70 and a one year high of $22.20. The business’s fifty day moving average is $5.16 and its two-hundred day moving average is $6.55.
Basel Medical Group (NASDAQ:BMGL – Get Free Report) last announced its quarterly earnings results on Friday, June 26th. The company reported $0.01 earnings per share for the quarter. The firm had revenue of $3.21 million during the quarter.
Analyst Upgrades and Downgrades
Read Our Latest Stock Report on Basel Medical Group
About Basel Medical Group
Basel Medical Group Ltd. is an investment holding company, which engages in providing orthopedic surgeries, medical care, and diagnosis services. Its services include orthopedic surgeries, medical care, rehabilitative therapy, physiotherapy, non-surgical treatments, medical diagnosis, magnetic resonance imaging, general surgery, x-ray, lump removal, sports medicine, and total hip replacement. The company was founded by Man Hing Yip on August 10, 2023 and is headquartered in Singapore.
Featured Stories
- Five stocks we like better than Basel Medical Group
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for Basel Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Basel Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
